Physician profile
Patrick Arnold
NPI 1225034671
$652.37
in general payments reported to CMS, 2019-2025
16 companies · $43.39 in 2025
The $43.39 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $115 · 2020: $39.41 · 2021: $126 · 2022: $67.37 · 2023: $210 · 2024: $50.85 · 2025: $43.39.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $287 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $286.78 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $132.03 | 2023 | |
| Novartis Pharmaceuticals Corporation | $126.49 | 2021-2023 | |
| Sun Pharmaceutical Industries INC. | $51.18 | 2019-2024 | |
| Tarsus Pharmaceuticals, INC. | $43.39 | 2025 | Xdemvy |
| Horizon Therapeutics Plc | $39.94 | 2020-2021 | |
| Ocular Therapeutix, INC. | $39.04 | 2021 | |
| Shire North American Group INC | $37.34 | 2019 | |
| Travere Therapeutics, INC. | $27.42 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $26.64 | 2019 | |
| Eyevance Pharmaceuticals LLC | $22.91 | 2020 | |
| Abbvie INC. | $22.78 | 2024 | |
| Alcon Vision LLC | $21.41 | 2021 | |
| Bausch & Lomb Americas INC. | $17.84 | 2023 | Miebo |
| Allergan, INC. | $15.46 | 2021 | |
| Rxsight INC | $14.29 | 2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Rayner Intraocular Lenses Limited | $14.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Arnold listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.